Ferro, A.; Campora, M.; Caldara, A.; De Lisi, D.; Lorenzi, M.; Monteverdi, S.; Mihai, R.; Bisio, A.; Dipasquale, M.; Caffo, O.;
et al. Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer. J. Clin. Med. 2024, 13, 3611.
https://doi.org/10.3390/jcm13123611
AMA Style
Ferro A, Campora M, Caldara A, De Lisi D, Lorenzi M, Monteverdi S, Mihai R, Bisio A, Dipasquale M, Caffo O,
et al. Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer. Journal of Clinical Medicine. 2024; 13(12):3611.
https://doi.org/10.3390/jcm13123611
Chicago/Turabian Style
Ferro, Antonella, Michela Campora, Alessia Caldara, Delia De Lisi, Martina Lorenzi, Sara Monteverdi, Raluca Mihai, Alessandra Bisio, Mariachiara Dipasquale, Orazio Caffo,
and et al. 2024. "Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer" Journal of Clinical Medicine 13, no. 12: 3611.
https://doi.org/10.3390/jcm13123611
APA Style
Ferro, A., Campora, M., Caldara, A., De Lisi, D., Lorenzi, M., Monteverdi, S., Mihai, R., Bisio, A., Dipasquale, M., Caffo, O., & Ciribilli, Y.
(2024). Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer. Journal of Clinical Medicine, 13(12), 3611.
https://doi.org/10.3390/jcm13123611